English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Mar 25, 2026

Researchers report hepatitis C drug may stop hepatitis E virus replication

Patient Daily | Mar 25, 2026

Oral semaglutide does not slow early Alzheimer’s decline in phase 3 trials, study finds

Patient Daily | Mar 25, 2026

GLP-1 drugs cut heart and kidney risks in type 1 diabetes study

Patient Daily | Mar 25, 2026

Experts discuss evolving guidelines for blood pressure control in older adults

Patient Daily | Mar 25, 2026

Losing health insurance worsens diabetes outcomes in low-income adults

Patient Daily | Mar 25, 2026

Study finds addiction risk tied to reward and impulse genes

Patient Daily | Mar 24, 2026

Researchers identify new immune response mechanism with implications for cancer treatment

Patient Daily | Mar 23, 2026

Ohio State Wexner Medical Center highlights role of palliative care for serious illness

Trending

+ Regulatory
A. D. Alderman | Jun 11, 2026

Pharmacist Crisp on PBM reform bills: 'Middleman that owns the pharmacy, sets the price, pays itself, and audits its own books'

+ Regulatory
A. D. Ahrens | Jun 11, 2026

Economist: 'The 340B program has been hijacked by tax-exempt hospitals'

+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'

+ Regulatory
Patient Daily | Jun 12, 2026

Taxpayer advocate: 340B drug discount program offers 'perverse incentives'

  • « First
  • «
  • …
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily